Stock market analysts and brokers have recently amended their target prices on shares of Vanda Pharmaceuticals Inc. (VNDA). According to the latest research reports released, 2 analysts have issued a rating of “buy”, 3 analysts …
Insider Monkey’s small-cap hedge fund strategy defeated ... That figure was $192 million in VNDA’s case. Agenus Inc (NASDAQ:AGEN) is the most popular stock in this table. On the other hand Carriage Services, Inc. (NYSE:CSV) is the …
Looking back to 72 days ago, Vanda Pharmaceuticals Inc (Symbol: VNDA) priced a 5,000,000 share secondary stock offering at $11.60 per share. Buyers in that offering made a considerable investment into the company, expecting that …
Vanda Pharmaceuticals, Inc. (VNDA - Free Report) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the …
On April 18, 2013, Vanda Pharmaceuticals (NASDAQ:VNDA) stock reached a 52-week high. Why? Until recently, many investors had given up on the Washington, DC-based pharmaceutical company. The reason was Fanapt (iloperidone), …
Vanda
Another better-ranked stock in the same industry is Anika Therapeutics Inc. ANIK, sporting a Zacks Rank #1 (Strong Buy). Is VNDA going up? Or down? Predict to see what others think: Up or Down Want the latest recommendations from …
Stock market analysts watching Vanda Pharmaceuticals Inc. (VNDA) have recently changed their ratings on the stock. The latest reports which are outstanding on Thursday 27th of April state 2 analysts have a rating of “strong buy”, 3 …
Vanda
WASHINGTON, March 29, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an …
University of California, San Francisco
Bllionaire hedge fund magnate John Paulson bought into the biopharmaceutical company at the start of the year and as of the third quarter holds 3.25 million VNDA shares. The stock has gained +12.13% year-to-date. Receptos Inc …
It appears that traders were closing out of prior bullish bets in the stock, as much of the call volume looked closing. 6. VNDA – There was one piece of good news in the biotech space, Novartis (NVS) and Vanda Pharma (VNDA), agreed to …